
Stem Cells for Safer Medicines, an independent not-for-profit company, has been founded via a consortium attracting both public and industry investment, including three major international pharmaceutical companies - GlaxoSmithKline, AstraZeneca and Roche.
Public sector funding is coordinated by the Technology Strategy Board, with contributions from the Department of Health, the Department for Innovation, Universities and Skills (DIUS), the Scottish Government, the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council (BBSRC).
Stem Cells for Safer Medicines is open to new members.
For further information, please contact us.